Jane is a long-term cancer survivor and active advocate. While her advocacy is largely rooted in her own experiences, it is also informed by her formal training in cognitive psychology and experimental methods (Ph.D.), computer and information science (MS) and business (MBA), as well as her career experiences which included many years in academia, not-for-profit R&D, corporate senior management and independent consulting.
Much of her advocacy has focused on clinical trials--ensuring that the patient voice is considered in selection of research questions, design of trial protocols that are sensitive to patient issues, and encouraging innovation to increase the speed of developing new treatments. She is especially interested in innovative trial designs that can speed new treatments to patients who need them. She has been involved with several clinical trial consortia and served on the steering committee and DMCs, of multiple cancer trials.
Jane has also been involved in health advocacy beyond cancer. For example, she has been involved in projects with CTTI, FOCR, RUF, MRCT NCI, and NAS. She is past-chair of PCORI’s Patient Engagement Advisory Panel and a current member of their Clinical Trials Advisory Committee.